Content ProductionClinical-stage biotech, preparing a Series C raise

Turning a clinical-stage CSO's expertise into an investor-ready narrative

+150%

CSO LinkedIn engagement in four months

The bottleneck

The science was strong, but the only people who could describe it accurately had no time and less interest in writing publicly. Investor and BD conversations kept starting from zero instead of from a credible public narrative.

What we did

Monthly structured interviews with the CSO, turned into an executive thought-leadership track for LinkedIn and investor-relevant framing — alongside technical briefs written for a BD audience that needed to understand the platform without a PhD.

The outcome

+150%

CSO LinkedIn engagement in four months

Standard

Technical briefs became pre-read for every BD conversation

>50%

Less “explain the science from scratch” time on first calls

This engagement runs under NDA. The firmographic detail and the numbers are audited; the client name is not shown.

Request a written diagnosis →About Content Production →